Does the Duration of Cardiopulmonary Bypass or Aortic Cross-Clamp, in the Absence of Blood and/or Blood Product Administration, Influence the IL-6 Response to Cardiac Surgery?

This publication has 25 references indexed in Scilit:

• Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting
  The Annals of Thoracic Surgery, 1996
• Attenuation of cardiopulmonary bypass–derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations
  The Journal of Thoracic and Cardiovascular Surgery, 1996
• Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage
  The Journal of Thoracic and Cardiovascular Surgery, 1995
• The Role of the Plasma from Platelet Concentrates in Transfusion Reactions
  New England Journal of Medicine, 1994
• Effect of Prestorage Leukocyte Removal on the Cytokine Levels in Stored Platelet Concentrates
  Vox Sanguinis, 1994
• Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators
  The Annals of Thoracic Surgery, 1993
• Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL‐6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL‐6 levels and febrile transfusion reactions
  Transfusion, 1993
• Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass
  The Annals of Thoracic Surgery, 1991
• Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation
  Clinical Immunology and Immunopathology, 1989
• Biventricular Function after Myocardial Revascularization in Humans
  Anesthesiology, 1985